Lumito
Presence
Lumito is a company listed under the stock ticker LUMITO (SE).
Executives
View the org chart displaying its 9 main executives
Most searched biographies at Lumito
- Mattias Lundin, Chief Executive Officer
- Ingrid Hultgren, Board Member
- Urban Widén, Chairman of the Board
Create your alert
to follow the executive moves at Lumito.
Biotechnology
Lumito has 2,289 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
- Bruker has announced the acquisition of NanoString Technologies (posted on May 13 2024).
- Aardvark Therapeutics has just announced a $85 Million fundraising (posted on May 12 2024).
Popular contacts in Biotechnology
News
Press releases by Lumito
- Lumito AB publishes Quarterly Report 4, 2023 | Lumito
- Research group at the Tyndall National Institute got an article published on the use of up-converting nanoparticles | Lumito
- Conversion of paid subscribed units (BTU) and first day of trading with warrants of series TO5 and TO6 | Lumito
- Lumitos issue of warrants is fully subscribed multiple times | Lumito
- Last day of trading with unit rights in Lumito | Lumito
- Lumito publishes prospectus in connection with issue of warrants | Lumito
- The subscription period in Lumito’s issue of warrants begins today | Lumito
- Lumito notifies changes to terms for the issue of free-of-charge warrants | Lumito
- Lumito secures loan of SEK 20 million and carries out an issue of warrants free-of-charge to shareholders and the lender | Lumito
- Lumito attends the Digital Pathology & AI Congress in London | Lumito
- View more press releases Close
Social media about Lumito
- Lumito on Wikipedia, Google News & Yahoo Finance
- Lumito on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Urban Widén 
